Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.

Learn More
Search temple health
EXPLORE TEMPLEHEALTH.ORG
ADDITIONAL LINKS

Head & Neck Institute

800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH
Head & Neck Institute

Publications & Presentations

Temple Head & Neck Institute Newsletter

Head Neck - For Physicians - Publications Presentations

Newsletter Issues

Publications & Presentations

Selected Publications: 2016-2017

  1. Adelman J, Shaigany K, McLean C, Krouse JH.  The role of surgery in management of Samter's triad:  A systematic review. Otolaryngol Head Neck Surg, 2016;154:220-37.
  2. Chan NJ, Soliman AM.  Angiotensin converting enzyme inhibitor-related angioedema:  Onset, presentation, and management. Ann Otol Rhinol Laryngol 2015;124:89-96.
  3. Galloway TJ, Ridge JA.  Management of squamous cancer metastatic to cervical nodes with an unknown primary site. J Clin Oncol 2015 Oct 10;33(29):3328-37.
  4. Isaacson G, Ianacone DC, Wolfson MR.  Ex vivo ovine model for pediatric flexible laryngoscopy training. Int J Ped Otorhinolaryngol, 2015 Dec;79(12):2196-9. 
  5. Jamal N, Erman A, Chhetri DK. Partial epiglottoplasty for pharyngeal dysphagia due to cervical spine pathology. Otolaryngol Head Neck Surg 2015;153(4):586-92. 
  6. Kamrava B, Mukherjee A, Weaver M, Roehm PC. Temporal malignant solitary fibrous tumor. Otol Neurotol 2016;27(5):e185-6.
  7. Krouse JH. Allergy and laryngeal disorders. Curr Opin Otolaryngol Head Neck Surg, 2016;24:221-5.
  8. Lango MN, Galloway TJ, Mehra R, Ebersole B, Liu JC, Moran K, Ridge JA. Impact of baseline patient-reported dysphagia on acute gastrostomy placement in patients with head and neck squamous cell carcinoma undergoing definitive radiation. Head Neck 2016 Apr;38 Suppl 1:E1318-24.
  9. Liu JC, Pynnonen MA, St John M, Rosenthal EL, Couch ME, Schmalbach CE. Grant-writing pearls and pitfalls: maximizing funding opportunities. Otolaryngol Head Neck Surg 2016 Feb;154(2):226-32.
  10. Murphy CT, Devarajan K, Wang LS, Mehra R, Ridge JA, Fundakowski CE, Galloway T. Pre-treatment tumor-specific growth rate as a temporal biomarker that predicts treatment failure and improves risk stratification for oropharyngeal cancer. Oral Oncol 2015;51(11):1034-40.
  11. Roehm PC, Shekarabi M, Wollebo H, Bellizzi A, He L, Salkin J, Khalili K. Inhibition of HSV-1 replication by gene editing strategy,” Scientific Reports 2016, 6:23146.
  12. Toskala E, Kennedy DW. Asthma risk factors. Int Forum Allergy Rhinol 2015 Sep;5 Suppl 1:S11-6.